Literature DB >> 25225641

Ulcer dressings and management.

Geoff Sussman1.   

Abstract

BACKGROUND: Chronic leg ulcers caused by venous disease, arterial disease or a combination of both need to be clearly identified before treatment can be commenced. Their management will depend on the diagnosis, combining direct management of the ulcer as well as management of patient factors. Other chronic wounds commonly observed in practice include pressure wounds, skin tears, atypical leg ulcers.
OBJECTIVE: This paper will outline a simple way to manage people with chronic ulcers.
CONCLUSION: Conclusion The prevalence of chronic wounds is expected to rise given that people are living longer and that the incidence of diabetes is increasing. There is a need is to clearly identify the underlying cause of any wound, including factors that may delay healing, and to treat appropriately. Treatment should address the wound environment, tissue base, presence of bacteria and the level of slough. If there is no improvement in wound healing after 4 weeks then seek help from a wound specialist. DISCUSSION: The prevalence of chronic ulcers in Australia has been estimated at 2-5%. Comprehensive assessment of the ulcer, the region and the whole person is an important first step in treatment. The aim of management is to promote healing and minimise the impact on the patient.

Entities:  

Mesh:

Year:  2014        PMID: 25225641

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  3 in total

1.  The combination of mesoglycan and VEGF promotes skin wound repair by enhancing the activation of endothelial cells and fibroblasts and their cross-talk.

Authors:  Raffaella Belvedere; Nunzia Novizio; Silvana Morello; Antonello Petrella
Journal:  Sci Rep       Date:  2022-06-30       Impact factor: 4.996

2.  Wound coverage by the linen dressing accelerates ulcer healing.

Authors:  Katarzyna Skórkowska-Telichowska; Justyna Mierziak-Darecka; Magdalena Wrobel-Kwiatkowska; Tomasz Gebarowski; Jan Szopa; Magdalena Zuk
Journal:  Postepy Dermatol Alergol       Date:  2021-11-05       Impact factor: 1.837

3.  Pilot parallel randomised controlled trial of protective socks against usual care to reduce skin tears in high risk people: 'STOPCUTS'.

Authors:  Roy J Powell; Christopher J Hayward; Caroline L Snelgrove; Kathleen Polverino; Linda Park; Rohan Chauhan; Philip H Evans; Rachel Byford; Carolyn Charman; Christopher J W Foy; Colin Pritchard; Andrew Kingsley
Journal:  Pilot Feasibility Stud       Date:  2017-10-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.